ERBB2 and breast cancer: The classification of BC by hormonal status has important therapeutic implications, as luminal-like cases may be treated using hormonal therapy, which is ineffective against HER2-positive and triple-negative breast cancer (Slamon et al., 1987; Fisher et al., 1989; Perou, 2011).